相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gait Alterations in Healthy Carriers of the LRRK2 G2019S Mutation
Anat Mirelman et al.
ANNALS OF NEUROLOGY (2011)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
Transgenic animal models of neurodegeneration based on human genetic studies
Brandon K. Harvey et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
α-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies
Youngshin Lim et al.
JOURNAL OF NEUROSCIENCE (2011)
Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model
Kang-Woo Lee et al.
JOURNAL OF NEUROSCIENCE (2011)
Elevated Tonic Extracellular Dopamine Concentration and Altered Dopamine Modulation of Synaptic Activity Precede Dopamine Loss in the Striatum of Mice Overexpressing Human α-Synuclein
Hoa A. Lam et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
Sheila M. Fleming et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Modelling of Parkinson's disease in mice
Marie-Francoise Chesselet et al.
LANCET NEUROLOGY (2011)
Priorities in Parkinson's disease research
Wassilios G. Meissner et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee
Taye H. Hamza et al.
PLOS GENETICS (2011)
Genome-Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
Todd L. Edwards et al.
ANNALS OF HUMAN GENETICS (2010)
Clinical Progression in Parkinson Disease and the Neurobiology of Axons
Hsiao-Chun Cheng et al.
ANNALS OF NEUROLOGY (2010)
Paraoxonase 1, Agricultural Organophosphate Exposure, and Parkinson Disease
Angelika D. Manthripragada et al.
EPIDEMIOLOGY (2010)
Balance is the challenge - The impact of mitochondrial dynamics in Parkinson's disease
Lena F. Burbulla et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
Andrew O. Koob et al.
EXPERIMENTAL NEUROLOGY (2010)
Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes
Yien-Ming Kuo et al.
HUMAN MOLECULAR GENETICS (2010)
TRO40303, a New Cardioprotective Compound, Inhibits Mitochondrial Permeability Transition
Sophie Schaller et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Clinical neuroprotection in Parkinson's disease - Still waiting for the breakthrough
Matthias Loehe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Dopamine Turnover Increases in Asymptomatic LRRK2 Mutations Carriers
Vesna Sossi et al.
MOVEMENT DISORDERS (2010)
Parkinson's disease: a model dilemma
M. Flint Beal
NATURE (2010)
The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons
Hakeem O. Lawal et al.
NEUROBIOLOGY OF DISEASE (2010)
alpha-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson's Disease
Nicole M. Gatto et al.
NEUROEPIDEMIOLOGY (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
A flexible sequential learning deficit in patients with Parkinson's disease: a 2 x 8 button-press task
Hiroko Mochizuki-Kawai et al.
EXPERIMENTAL BRAIN RESEARCH (2010)
Meeting Report: Consensus Statement-Parkinson's Disease and the Environment: Collaborative on Health and the Environment and Parkinson's Action Network (CHE PAN) Conference 26-28 June 2007
Jeff Bronstein et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Dopamine Transporter Genetic Variants and Pesticides in Parkinson's Disease
Beate R. Ritz et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein
Franz Marxreiter et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Medical records documentation of constipation preceding Parkinson disease A case-control study
R. Savica et al.
NEUROLOGY (2009)
The scientific and clinical basis for the treatment of Parkinson disease (2009)
C. Warren Olanow et al.
NEUROLOGY (2009)
Behavioural and neurochemical response of α-synuclein A30P transgenic mice to the effects of L-DOPA
Mari Oksman et al.
NEUROPHARMACOLOGY (2009)
ALTERATIONS IN CORTICOSTRIATAL SYNAPTIC PLASTICITY IN MICE OVEREXPRESSING HUMAN α-SYNUCLEIN
J. B. Watson et al.
NEUROSCIENCE (2009)
Targeting Neuroprotection as an Alternative Approach to Preventing and Treating Neuropathic Pain
Thierry Bordet et al.
NEUROTHERAPEUTICS (2009)
Toxic effects of dopamine metabolism in Parkinson's disease
Nobutaka Hattori et al.
PARKINSONISM & RELATED DISORDERS (2009)
Association of olfactory dysfunction with risk for future Parkinson's disease
G. Webster Ross et al.
ANNALS OF NEUROLOGY (2008)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Olfactory deficits in mice overexpressing human wildtype α-synuclein
Sheila M. Fleming et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Selective loss of nigral dopamine neurons induced by overexpression of truncated human α-synuclein in mice
Masaki Wakamatsu et al.
NEUROBIOLOGY OF AGING (2008)
Abnormal colonic motility in mice overexpressing human wild-type α-synuclein
Lixin Wang et al.
NEUROREPORT (2008)
Parkinson's disease: a dual-hit hypothesis
C. H. Hawkes et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Behavioral and histopathological consequences of paraquat intoxication in mice:: Effects of α-synuclein over-expression
P. O. Fernagut et al.
SYNAPSE (2007)
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
K. S. Rommelfanger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
David Sulzer
TRENDS IN NEUROSCIENCES (2007)
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein
S. M. Fleming et al.
NEUROSCIENCE (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease
R Cools
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2006)
Excessive daytime sleepiness and subsequent development of Parkinson disease
RD Abbott et al.
NEUROLOGY (2005)
Cognitive predictors of dementia in Parkinson's disease: A community-based, 4-year longitudinal study
CC Janvin et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP
DD Song et al.
EXPERIMENTAL NEUROLOGY (2004)
Regional distribution of proteinase K-resistant α-synuclein correlates with Lewy body disease stage
M Neumann et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Behavioral and neurochemical effects of wild-type and mutated human α-synuclein in transgenic mice
EK Richfield et al.
EXPERIMENTAL NEUROLOGY (2002)
Frequency of bowel movements and the future risk of Parkinson's disease
RD Abbott et al.
NEUROLOGY (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
分享论文
